Epidemiology of human pulmonary infection with nontuberculous mycobacteria

Clinics in Chest Medicine

Volumn 23, Issue 3, 2002, Pages 553-567

  Marras, Theodore K ^a,c   Daley, Charles L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c Division of Pulmonary and Critical Care Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AUSTRALIA; CANCER SUSCEPTIBILITY; CHRONIC LUNG DISEASE; CYSTIC FIBROSIS; CZECH REPUBLIC; EUROPE; GENDER; GEOGRAPHIC DISTRIBUTION; HEALTH STATISTICS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; INFECTION RATE; INTERMETHOD COMPARISON; JAPAN; LUNG INFECTION; MINER; MYCOBACTERIOSIS; MYCOBACTERIUM KANSASII; NORTH AMERICA; PNEUMOCONIOSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOUTH AFRICA; SWEDEN; SYMPTOMATOLOGY; VIRULENCE; WARMING; WATER CONTAMINATION;

HUMANS; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL; RISK FACTORS; TUBERCULOSIS, PULMONARY; WORLD HEALTH;

EID: 0036740665     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(02)00019-9     Document Type: Review

References (69)

1. Flick LF. Development of our knowledge of tuberculosis. Philadelphia: Wickersham; 1925.
2. Branch A. Avian tubercle bacillus infection, with special reference to mammals and to man: its reported association with Hodgkin's disease. Arch Pathol 1931; 12:253-74.
3. Branch A. A study of acid-fast organisms other than mammalian tubercle bacilli isolated from disease in man. Tubercle 1933;14:337-53.
4. Griffith AS. Observations on the "M" strain of acidfast bacilli. Tubercle 1933;15:53-9.
5. Cummins SL, Williams EM. An "acid-fast" other than Koch's Bacillus cultivated from sputum. Tubercle 1933;15:48-53.
6. Fogan L. Atypical mycobacteria. Medicine (Baltimore) 1970;49:243-55.
7. Pinner M. Atypical acid-fast microorganisms: III. Chromogenic acid-fast bacilli from human beings. American Review of Tuberculosis 1935;32:424-39.
8. Runyon EH. Anonymous mycobacteria in pulmonary disease. Med Clin North Am 1961;43:273-90.
9. American Thoracic Society. Status of disease due to unclassified mycobacteria. Am Rev Respir Dis 1963; 87:459-61.
10. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156[2(2)]:S1-S19.
11. Wolinsky E, Rynearson TK. Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis 1968;97:1032-7.
12. Portaels F. Epidemiology of mycobacterial diseases. Clin Dermatol 1995;13:207-22.
13. Falkinham JO. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 1996;9: 177-215.
14. O'Brien RJ, Geiter LJ, Snider Jr. DE. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis 1987;135(5):1007-14.
15. Good RC. Isolation of non-tuberculous mycobacteria in the United States, 1979. J Infect Dis 1980;142:779-83.
16. Tsukamura M, Kita N, Shimoide H, Arakawa H, Kuze A. Studies on the epidemiology of nontuberculous mycobacteriosis in Japan. Am Rev Respir Dis 1988; 137:1280-4.
17. Palmer CE. Tuberculin sensitivity and contact with tuberculosis. American Review of Tuberculosis 1953; 68:678-94.
18. Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. Clinical and laboratory studies of tuberculosis and respiratory disease: the navy recruit program. Am Rev Respir Dis 1969;99[4(2)]:1-132.
19. Trnka L, Dankova D, Svandova E. Six years' experience with the discontinuation of BCG vaccination: 4. protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex. Tuber Lung Dis 1994;75:348-52.
20. Larsson LO, Bentzon MW, Lind A, Magnusson M, Sandegard G, Skoogh BE, et al. Sensitivity to sensitins and tuberculin in Swedish children. Pt 5: a study of school children in an inland rural area. Tuber Lung Dis 1993;74:371-6.
21. Kwamanga DO, Swai OB, Agwanda R, Githui W. Effect of non-tuberculous mycobacteria infection on tuberculin results among primary school children in Kenya. East Afr Med J 1995;72:222-7.
22. Abrahams EW, Silverstone H. Epidemiological evidence of the presence of non-tuberculous sensitivity to tuberculin in Queensland. Tubercle 1961;42: 487-99.
23. Smyth JT, Porter RM. Geographic variations in the prevalence of sensitivity to PPD-S and PPD-B in Westem Australia. Tubercle 1967;48:273-80.
24. Brown P, Cathala F, Gajdusek C. Mycobacterial and fungal skin sensitivity patterns among remote population groups in Papua New Guinea, and in the New Hebrides, Solomon, and Caroline Islands. Am J Trop Med Hyg 1981;30:1085-93.
25. Robakiewicz M, Grzybowski S. Epidemiological aspects of non-tuberculous mycobacterial disease and of tuberculosis in British Columbia. Am Rev Respir Dis 1974;109:613-20.
26. Grzybowski S, Brown MT, Stothard D. Infections with atypical mycobacteria in British Columbia. CMAJ 1969;100:896-900.
27. Frappier-Davignon L, Fortin R, Desy M. Sensitivity to "atypical" mycobacteria in high school children in two community health departments. Canadian Journal of Public Health 1989;80:335-8.
28. Furculow ML, Hewell B, Nelson WE, Palmer CE. Quantitative studies of the tuberculin reaction. US Public Health Reports 1941;56:1082-100.
29. Fogan L. PPD antigens and the diagnosis of mycobacterial diseases. Arch Intern Med 1969;124:49-54.
30. Sackett DL. Bias in analytic research. J Chronic Dis 1979;32:51-63.
31. Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989;321:863-8.
32. Choudhri S, Manfreda J, Wolfe J, Parker S, Long R. Clinical significance of nontuberculous mycobacteria isolates in a Canadian tertiary care center. Clin Infect Dis 1995;21:128-33.
33. Good RC, Snider Jr. DE. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 1982;146:829-33.
34. Robinson BL, Grzybowski S, Bowmer EJ, McDiarmid J, Whittaker EI, Tanner K. Atypical mycobacterial disease in British Columbia, 1960-1967. CMAJ 1969; 101:17-24.
35. DuMoulin GC, Sherman IH, Hoaglin DC, Stottmeier KD. Mycobacterium avium complex, an emerging pathogen in Massachusetts. J Clin Microbiol 1985; 22:9-12.
36. Butler RW, Josephson JE. Unclassified mycobacteria isolated from human suspect tuberculosis cases in Newfoundland. CMAJ 1963;88:347-50.
37. Isaac-Renton JL, Allen EA, Chao CW, Grzybowski S, Whittaker EI, Black WA. Isolation and geographic distribution of Mycobacterium other than M. tuberculosis in British Columbia, 1972-81. CMAJ 1985;133(6): 573-6.
38. Ahn CH, Lowell JR, Onstad GD, Shuford EH, Hurst GA. A demographic study of disease due to Mycobacterium kansasii or M intracellulare-avium in Texas. Chest 1979;75:120-5.
39. Bloch KC, Zwerling L, Pletcher MJ, Hahn JA, Gerberding JL, Ostroff SM, et al. Incidence and clinical implications of isolation of Mycobacterium kansasii: Results of a 5-year, population-based study. Ann Intern Med 1998;129:698-704.
40. Barrera L, DeKantor IN. Nontuberculous mycobacteria and Mycobacterium bovis as a cause of human disease in Argentina. Trop Geogr Med 1987;39:222-7.
41. Tala E, Viljanen M. Mycobacterial infections in Finland. Scand J Infect Dis 1995;98S:7-8.
42. Marks J. "Opportunist" mycobacteria in England and Wales. Tubercle 1969;50(S1):78-80.
43. Jenkins PA. The epidemiology of opportunist mycobacterial ionfections in Wales, 1952-1978. Rev Infect Dis 1981;3:1021-3.
44. France AJ, McLeod DT, Calder MA, Seaton A. Mycobacterium malmoense infections in Scotland: an increasing problem. Thorax 1987;42:593-5.
45. Bollert FGE, Watt B, Greening AP, Crompton GK. Non-tuberculous pulmonary infections in Scotland: a cluster in Lothian? Thorax 1995;50:188-90.
46. Lortholary O, Deniel F, Boudon P, LePennec MP, Mathieu M, Soilleux M, et al. Mycobacterium kansasii infection in a Paris suburb: comparison of disease presentation and outcome according to human immunodeficiency virus status. International Journal of Tuberculous Lung Disease 1999;3:68-73.
47. Engel HWB, Berwald LG, Lindeboom BW, Havelaar AH. Mycobacterium kansasii infections in the Netherlands: a brief summary. Rev Infect Dis 1981;3:1024.
48. Debrunner M, Salfinger M, Brandli O, von Graevenitz A. Epidemiology and clinical significance of nontuberculous mycobacteria in patients negative for human immunodeficiency virus in Switzerland. Clin Infect Dis 1992;15(2):330-45.
49. Kubin M, Svandova E, Medek B, Chobot S, Olsovsky Z. Mycobacterium kansasii infection in an endemic area of Czechoslovakia. Tubercle 1980;61:207-12.
50. Kaustova J, Chmelik M, Ettlova D, Hudec V, Lazarova H, Richtrova S. Disease due to Mycobacterium kansasii in the Czech Republic: 1984-1989. Tuber Lung Dis 1995;76:205-9.
51. Chobot S, Malis J, Sebakova H, Pelikan M, Zatloukal O, Palicka P, et al. Endemic analysis of infections caused by Mycobacterium kansasii in the Karvina district in 1968-1995: an analysis of epidemiological data. Cent Eur J Public Health 1997;5: 164-73.
52. Corbett EL, Blumberg L, Churchyard GJ, Moloi M, Mallory K, Clayton T, et al. Nontuberculous mycobacteria: Defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med 1999;160:15-21.
53. Corbett EL, Hay M, Churchyard GJ, Herselman P, Clayton T, Williams BG, et al. Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology. International Journal of Tuberculous Lung Disease 1999;3:501-7.
54. Arabin G, Gartig D, Kleeberg HH. First tuberculosis prevalence in KwaZulu. S Afr Med J 1979;56:434-8.
55. Fourie PB, Gatner EMS, Glathaar E, Kleeberg HH. Followup tuberculosis prevalence survey of Transkei. Tubercle 1980;61:71-9.
56. Mycobacteriosis Research Group of the Japanese National Chest Hospitals. Rapid increase of the incidence of lung disease due to Mycobacterium kansasii in Japan. Chest 1983;83:890-2.
57. Sakatani M. The epidemiology of pulmonary disease caused by Mycobacterium avium complex in Japan. Kekkaku 1993;68(1):43-6.
58. Sakatani M. Epidemiology of non-tuberculous mycobacteriosis (NTM) in Japan. Japanese Journal of Thoracic Diseases 1994;32S:211-5.
59. Sakatani M. Nontuberculous mycobacteriosis (NTM) in Japan-epidemiologic and clinical study. Kekkaku 1994;69(2):119-24.
60. Shigeto E, Sato H, Kawahara S, Kuraoka T, Miyazawa T. The epidemiology of nontuberculous mycobacterial diseases in Hiroshima Prefecture. Kekkaku 1996;71 (9):513-8.
61. Sakatani M. Nontuberculous mycobacteriosis; the present status of epidemiology and clinical studies. Kekkaku 1999;74(4):377-84.
62. Hosker HSR, Lam CW, Ng TK, Ma HK, Chan SL. The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong. Respir Med 1995;89:3-8.
63. Edwards FGB. Disease caused by 'atypical' (opportunist) mycobacteria: a whole population review. Tubercle 1970;51:285-95.
64. Carruthers KJM, Edwards FGB. Atypical mycobacteria in Western Australia. Am Rev Respir Dis 1965; 91:887-95.
65. Pang SC. Mycobacterium kansasii infections in Western Australia (1962-1987). Respir Med 1991;85: 213-8.
66. O'Brien DP, Currie BJ, Krause VL. Nontuberculous mycobacterial disease in Northern Australia: a case series and review of the literature. Clin Infect Dis 2000;31:958-68.
67. Donnabella V, Salazar-Schicchi J, Bonk S, Hanna B, Rom WN. Increasing incidence of Mycobacterium xenopi at Bellevue Hospital: an emerging pathogen or a product of improved lasboratory methods? Chest 2000;118:1365-70.
68. Romanus V, Hallander HO, Wahlen P, Olinder-Nielsen AM, Magnusson PHW, Juhlin I. Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG vaccination coverage. Tuber Lung Dis 1995;76:300-10.
69. Iseman M. Mycobacterium avium complex and the normal host: the other side of the coin. N Engl J Med 1989;321:896-8.